Concepedia

JA Pietenpol

JP

Statistics

Publications

3

Citations

952

H-Index

3

Active since

1992

Affiliations

Vanderbilt-Ingram Cancer Center(Current)

JA Pietenpol is an author at Vanderbilt-Ingram Cancer Center specializing in oncology, medicine, and breast cancer chemotherapy.

Publications per year

1992–2013

3

Publications

3

Oncogenic forms of p53 inhibit p53-regulated gene expression

S E Kern, JA Pietenpol, Sam Thiagalingam et al. · Science · 1992 · 919 citations

, , +14

A Phase Ib Trial of RAD001, an mTOR Inhibitor, with Weekly Cisplatin and Paclitaxel in Patients with HER2-Negative Metastatic Breast Cancer.

IA Mayer, Howard A. Burris, Johanna C. Bendell et al. · Cancer Research · 2009 · 19 citations

, , +17

Abstract PD1-6: A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus (an mTOR inhibitor) in patients with stage II/III triple-negative breast cancer (TNBC)

IA Mayer, Bojana Jovanović, V Abramson et al. · Cancer Research · 2013 · 14 citations

, , +17

1–3 of 3